Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linezolid Dose-ranging in Pulmonary Tuberculosis
NCT02279875Phase 2Completed
- Sponsor
- TB Alliance
- Start
- Nov 2014
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of linezolid in pulmonary tuberculosis (TB), sponsored by TB Alliance. Started Nov 2014; status: completed.
02
Drugs
linezolid
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT02279875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02279875.